1 Followers
25 Following
Sapanas

Sapanas

Aortic Coarctation Market 2019 Global Trends, Market Share, Industry Size, Growth, Opportunities And Forecast To 2022

Global Aortic Coarctation Market Information, by treatment (Balloon angioplasty, Patch aortoplasty, Subclavian flap aortoplasty and others), by end user (Hospital, Clinic, Cardiac Institutes and others) - Forecast to 2022

 

Aortic Coarctation Market Overview

Market Research Future published a Half-Cooked research report on Aortic Coarctation Market Research Report- Global Forecast to 2022.

 

Coarctation of the aorta (CoA) in layman’s term is contraction of aorta; the condition accounts for close 5-8% of all congenital heart defects. There is growing market for the treatment of disease mainly due to rising prevalence. As per the report published by Market Research Future (MRFR) the global aortic coarctation market is set to demonstrate a compound annual growth rate (CAGR) of 3.8% till 2022.

 

CoA may develop as an isolated defect or may be caused by some other abrasion like ventricular septal defect (VSD) and bicuspid aortic valve. In several cases, the issue is identified in infantile period with symptoms arising within the first twelve month after birth.

According to the information available in US National Library of Medicine National Institutes of Health, CoA is a relative common type of congenital heart disease. CoA incidence rate in around 3 cases per 10000 births. It is considered as a diverse form of abrasion which may be found across all age groups. In 1944, a surgical repair for aortic coarctation was defined for the first time. Today, a slew of surgical techniques is available for the condition. Over the years, the treatment for CoA has improved substantially. Some of the common techniques include endovascular stent placement and transcatheter balloon angioplasty. These procedures are highly advanced and are among minimally invasive approaches. However, determination of the treatment approach entirely depends on the severity of the condition.

 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1854

 

Patients undergoing CoA treatment must requirement monitoring over their lifetime as complication such as aortic aneurysm, recoarctation, persistent hypertension are a highly possibility. Increased effort towards developing safer treatment option of AoC is expected to support the growth of the global aortic coarctation market. Care givers are looking into outcome and utilities of different treatment approaches aortic coarctation. Treatment approaches are heavily influenced by patient’s age, size, anatomy and clinical course.

 

Gobal Aortic Coarctation Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on treatment, end user and region.

 

On the basis of treatment, the market has been segmented into subclavian flap aortoplasty, patch aortoplasty, balloon angioplasty and other. Of these, the balloon angioplasty segment represents relatively high market share and is expected to retain its top position over 2022. On the basis of end user, the market has been segmented into cardiac institutes, clinic, hospital and others. 

 

Global Aortic Coarctation Market: Regional Analysis

On the basis of regions, the global market for aortic coarctation has been segmented into North America, Latin America, Europe, the Middle East & Africa (MEA) and Asia Pacific (APAC). Of these, North America represent the largest market for aortic coarctation market. During the forecast period, the market in North America is expected to exhibit a strong growth. Fuelled by the increased prevalence of heart disorders, the market in North America is expected to remain highly attractive in the years ahead. Meanwhile, Europe is expected retain its second spot over 2022. High healthcare expenditure and existence of an advanced healthcare system favours the market in the region. APAC has also emerged as a fast-growing market for aortic coarctation in recent years. Rising healthcare standard in countries such as China and India is creating opportunities for market in APAC.

 

Get More Information on Aortic Coarctation Market Research Report- Global Forecast to 2022 @ https://www.marketresearchfuture.com/reports/aortic-coarctation-market-1854

 

Global Aortic Coarctation Market: Competition Analysis

Some of the key companies operating in the global market for aortic coarctation include Medtronic (Ireland), Clada Medical Devices (Ireland), Creganna (Ireland), Braile Biomedica (Brazil), B. Braun Melsungen AG (Germany) and Freudenberg Medical, LLC (Germany).



Source: http://www.marketresearchfuture.com/reports/aortic-coarctation-market-1854

Sexual Wellness Market: Outlook, Growing By Top Company, Region, Application, Driver, Trends & Predictions

Sexual Wellness Market Analysis  

Sexual wellness market is predicted to grow at a 9.2% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report. Sexual wellness, simply out, means attainment of mental, physical, and sexual prosperity by individuals. This needs a respectful and positive approach to sexual relationships and sexuality, and also the possibility to have safe and pleasurable sexual experiences. Lubricants, condom, sex toys, sexual enhancement supplements, ointments, and contraceptives are some of the common sexual wellness products. Sexual health means having a positive relationship, experiencing intimacy, joy, and pleasure, and above all, avoiding unplanned pregnancies and sexually transmitted infections. 

 

Various factors are propelling the sexual wellness market growth. These factors, as per the new MRFR report, include increasing prevalence of sexually transmitted diseases worldwide, rise in awareness about sexual health items, development of e-commerce business, and favorable initiatives undertaken by the NGOs and government for promoting the use of contraceptives. Additional factors pushing market growth include increasing concern about personal hygiene, the growing interest for innovative sexual wellness products amongst youths, easy purchase and availability of products through online stores, and launch of innovative products such as organic oil-based lubricants, warming jelly, and flavored condoms.  

 

On the flip side, side effects owing to toxic ingredients in products, product recalls, societal hindrances and reservations, availability of alternatives for condoms, and imitation of products are factors that may deter the sexual wellness market growth over the forecast period. 

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7328

 

Sexual Wellness Market Segmentation 

The MRFR report provides a complete segmental analysis of the sexual wellness market report on the basis of distribution channels and product. 

 

Based on product, the sexual wellness market is segmented into ointments, lubricants, sexual enhancement supplements, condom and contraceptives, sex toys, and others. Of these, the sex toys segment will have the largest share in the market over the forecast period.  

 

Based on distribution channels, the sexual wellness market is segmented into online platforms and retail. The retail segment is again segmented into specialty stores, drug stores, and others. Of these, the retail segment will dominate the market over the forecast period. 

 

Sexual Wellness Market Regional Analysis 

By region, the sexual wellness market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will dominate the market over the forecast period. Factors aiding growth in the region include developed e-commerce business in the region, growing awareness about sexual health items, growing incidence of sexually transmitted diseases, and the presence of several key players.  

 

The sexual wellness market in Europe is predicted to have the second-largest share in the market over the forecast period. Factors aiding growth in the region include the growing prevalence of sexual dysfunction cases in the region and growing awareness about sexually transmitted diseases.  

 

The sexual wellness market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include advancement in healthcare facilities, rise in patient population, increasing use of sexual wellness toys, supportive sex education programs, and growing awareness regarding sexual wellness products.  

 

The sexual wellness market in the MEA is predicted to have a slow growth over the forecast period.  

 

Sexual Wellness Market Key Players 

Leading players profiled in the sexual wellness market report include BioFilm IP LLC (US), Mankind Pharma (India), Veru Inc. (US), Karex Berhad (Malaysia), LifeStyles Healthcare (Australia), Reckitt Benckiser Group plc (UK), Ansell Ltd. (Australia), Church & Dwight Co., Inc. (US), Doc Johnson (US), and LELO (Sweden). Various strategies have been incorporated by key players to create a foothold in the market such as mergers and acquisitions, partnerships/joint ventures, research and development activities, product launches and innovations, collaborations, and expansions.  

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/sexual-wellness-market-7328

 

Sexual Wellness Industry News/Update

September 2019: ACOG (American College of Obstetricians and Gynecologists committee has recently released recommendations on OTC (over the counter) access to hormonal contraceptives. All hormonal contraceptives such as vaginal rings, injections, patches, and pills will be available as OTC products without age restrictions.

 

Source: http://www.marketresearchfuture.com/reports/sexual-wellness-market-7328

Traumatic Brain Injuries (TBI) Treatment Market Size, Share, Growth, Analysis, Developments, Trends, And Forecast By 2023

Market Research Future has published a half-cooked research report on the global traumatic brain injuries (TBI) treatment market.  

 

Traumatic Brain Injuries (TBI) Treatment Market Overview

Traumatic brain injuries (TBI) refer to the concussion or damages to the skull, and the tissue beneath that occur due to some mental disturbance, during a road accident, or powerful shock wave on the battlefield. TBI is the leading cause of a chemical reaction triggered in the brain that ravages neurons and the networks that supply them nutrients & oxygen. Traumatic brain injuries can cause immediate, significant damage to a person's brain, leading to long-term cognitive, psychological, and motor system damage.

Hence, TBI is considered a severe health problem, contributing to a substantial number of deaths and permanent disability every year.

 

Every year, globally, around 52,000 people die of traumatic brain injuries, commonly caused by accidents, violent assaults, blunts force trauma, and sports injuries. Fortunately, there is a range of breakthrough diagnostics, drugs, and novel treatment procedures available in the market, helping the patients with early detection and treatment to manage the conditions, effectively.

 

As a result, the global traumatic brain injuries treatment market is a pervasively growing market space. The increasing prevalence of TBI and advancements in the therapeutics to manage the conditions are the major driving forces pushing the growth of the market. According to Market Research Future (MRFR), the global traumatic brain injuries treatment market is expected to perceive a phenomenal growth by 2023. MRFR, in its recently published analysis, also asserts that the market would register around 5.1% CAGR throughout the forecast period (2018 – 2023).

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6839

 

The increase in the uses of medicines to treat traumatic brain injuries treatment presage the rise in the cases diagnosed and treated. Additionally, factors such as the burgeoning healthcare sector and the increasing number of advanced cares providing facilities are substantiating the growth of the market. Growing R&D activities in the field of TBI diagnostics and drug & therapeutics discoveries are boosting the growth of the market. Furthermore, the rising number of road collisions and the increasing number of aging populations foster the growth of the market.

 

On the other hand, the prohibitive cost of treatment, along with the incidents of drug resistance and unmet clinical needs, is impeding the growth of the market. Nevertheless, the antibiotics developed with advent technologies would support the market growth throughout the review period, providing preferable outcomes. Also, the availability of several diagnostics and treatment options available, including behavioral intervention & prescription medication and digital medicines, would impact the market growth, positively. 

 

Global Traumatic Brain Injuries Treatment Market – Segments

The report is segmented into three dynamics to widen the scope of understanding,

By TreatmentImmediate emergency care, Medications, Surgery, Rehabilitation, and others.

By End-userHospitals, Neurologist, Independent pharmacies, Rehabilitative centre treatment, and others.

By RegionsNorth America, Europe, APAC, and the Rest-of-the-World.


Traumatic Brain Injuries Treatment Market - Geographical Analysis 

North America leads the global traumatic brain injuries treatment market. The largest share of the market attributes to a large patient pool suffering from traumatic brain injuries and high healthcare expenditures. The rising rate of TBI patients, hospitalizations, and deaths occurring due to TBI contributes to the growth of the regional market. The US accounts for the largest share in the North American TBI treatment market. 

 

The region is expected to retain its leading position in the global market throughout the forecast period, creating a substantial revenue pocket. Europe stands second in the global traumatic brain injuries treatment market. Factors such as increasing aging population and increasing prevalence of TBI across the region drive the growth of the market. Moreover, considerable advancements in medical technologies and digital medicines support the growth of the regional market. 

 

Also, the presence of a flourishing medical devices market and notable players, alongside, the rising healthcare expenditure in the region, support the market growth. According to the journal of neurosurgery, the overall rate of TBI incidences is highest in Europe, and about 95% population suffer from TBI occurred due to road accidents.

The Asia Pacific traumatic brain injuries treatment market is emerging as a promising market. Southeast Asian and Western Pacific region experiences the highest rate of TBI. Besides, rising head injuries that took place in road collisions are fostering the growth of the regional market. Moreover, large patient population and unmet needs, alongside the availability of low-cost treatment procedures, are acting as key driving forces behind the regional market. 

 

Global Traumatic Brain Injuries Treatment Market - Competitive Analysis

Highly competitive, the traumatic brain injuries treatment market appears fragmented, with various well-established players forming a competitive landscape. To gain a competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, expansion, and product launch. 

 

Traumatic Brain Injuries (TBI) Treatment Market Major Players: 

Players operating in the global traumatic brain injuries treatment market, include Zimmer Biomet, Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc. Teva Pharmaceutical Industries Ltd., Ischemic, Grace Laboratories LLC, Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals, Targacept, BioDirection, Inc., QuesGen Systems, Inc., BrainScope Company, Inc., Neural Analytics, Inc., Oculogica, BrainScope Company, Inc., Silver Creek Pharmaceuticals Inc., Stemedica Cell Technologies Inc., Banayan Biomarkers Inc., and Vasopharm GmbH, among others.

 

Industry/Innovations/Related News:

September 09, 2019 ---- Endonovo Therapeutics, Inc. (the US), a commercial-stage developer of non-invasive Electroceutical® therapeutic devices, announced its partnership with Veterans Healthcare Supply Solutions (VHSS - the US), to initiate the sales of SofPulse® in VH Administration and military hospitals. The collaboration with VHSS is a significant accomplishment for Endonovo, especially when it is planning to expand its business to support VA and military hospitals globally.

 

Endonovo develops non-invasive, electromagnetic therapy treatments for humans and animals. Its current portfolio of commercial & clinical-stage wearable Electroceuticals® therapeutic devices address traumatic brain injury (TBI), and other various pain and chronic diseases & disorder management treatments. Veterans Healthcare wholesales & distributes health care equipment, and related supplies & equipment. VHSS has recently expanded its reach to service all federal government agencies with a well-diversified portfolio of products.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/traumatic-brain-injuries-treatment-market-6839

 

Source: http://www.marketresearchfuture.com/reports/traumatic-brain-injuries-treatment-market-6839

Mitral Valve Stenosis Market 2019 Leading Growth Drivers, Emerging Audience, Segments And Forecast

Mitral Valve Stenosis Market Research Report: By Diagnostic Test (Electrocardiogram, Transthoracic Echocardiogram, Cardiac Catheterization), by Treatment (Medication, Procedure), by End User (Hospital, Diagnostic Centers) - Global Forecast till 2023

 

Mitral Valve Stenosis Market Overview

The narrowing down of the mitral valve obstructs the blood flow from the left atrium to the left ventricle of the heart. This medical condition is called mitral stenosis. The increase in occurrence of rheumatic fever is subsequently surging the number of people suffering from mitral stenosis. Additionally, an increase in patient pool afflicted with heart ailments is predicted. These factors are expected to bolster the global mitral valve stenosis market growth. The sedentary lifestyle  and changing food habits are also expected to cast a positive impact on the global mitral valve market growth. Technological updates are backing firm medical infrastructure. This is causing improvements in treatment. Hence, is likely to boost the market growth during the forecast period.

 

On the flip side, the high medical expense and restaints in the process of medical device approval can hinder the market expansion. 

 

Mitral Valve Stenosis Market Segmental Overview

The global mitral valve stenosis market has been segmented into treatment, diagnostic tests, and end user.

 

Based on the diagnostic test, the global mitral valve stenosis market has been segmented into transthoracic echocardiogram, cardiac catheterization, electrocardiogram (ECG), transesophageal echocardiogram, and others.

 

Based on the treatment, the global mitral valve stenosis market has been segmented into medication and procedures. The medication segment has been further classified into antibiotics, blood thinners, beta blockers, medication and procedures, diuretics, and anti-arrhythmic drugs. The procedures segment has been narrowed down to  mitral valve surgery and mitral valvuloplasty. The mitral valve surgery segment has been sub-segmented into and mitral valve replacement and mitral valve replacement. Due to the increase in number  of medical devices manufacturers, concerned with mitral valve stenosis, the procedure segment is expected to shape a assuring future of the mitral valve stenosis market over the review.

 

Based on the end-user, the global mitral valve stenosis market has been segmented into hospital and clinics, diagnostic centers, and others. 

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6560

 

Mitral Valve Stenosis Market Regional Analysis

Based on the region, the market growth has been analyzed across North America, South America, Asia Pacific, Europe, and the Middle East Asia.

 

MRFR identified that the global mitral valve stenosis market in the North and South American region  is expected to dominate, globally. Factors like the increase in prevalence of heart ailments, the surge in technical advancements backing medical infrastructural enhancements, and surge in the healthcare expenditure are likely to stimulate the regional market growth.

 

The increase in prevalence of cardiac malaises and the hike in healthcare expenditure in Europe are identified to bolster the regional mitral valve stenosis market growth. MRFR forecasts the European mitral valve stenosis market to hold the second largest market size, globally.

 

The mitral valve stenosis market in APAC is expected to grow at the fastest rate. The increase in medical tourism, upgradations in clinical trials regulations, the rapid adoption of advanced medical technologies, and availing special incentives for investing in making improvements in  the healthcare industry are factors that are likely to augment the regional market growth over the review period.

 

The Middle East Asia and Africa is anticipated to hold the least market share over the assessment period. However, the government’s significant move enhancing the medical base of the region can fuel the mitral valve stenosis market growth. 

 

Mitral Valve Stenosis Market Key Players

On-X Life Technologies, Inc., JenaValve Technology, Siemens Healthcare, Micro Interventional Devices, Inc., Boston Scientific Corporation, Abbott Laboratories, HighLife Medical, Neovasc Inc., Medtronic Plc, Edward Lifesciences, CryoLife, Inc., and Braun Melsungen AG. 

 

Mitral Valve Stenosis Industry Update

May 2019: LAMPOON Technique developed by researchers at National, Heart, Lung, and Blood Institute (NHLBI) to resolve left ventricular outflow tract (LVOT) obstruction complication in transcatheter mitral valve replacement (TMVR).

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/mitral-valve-stenosis-market-6560

 

Source: http://www.marketresearchfuture.com/reports/mitral-valve-stenosis-market-6560

Laxatives Market 2019 Global Size, Share, Growth Analysis, Segments, Current Trends And Regional Overview By Key Companies

Laxatives Market Overview

Global laxatives market size is expected to exhibit strong progress over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global laxatives market is profiled in detail in the report, which provides readers with a comprehensive overview of the market’s historical growth trajectory as well as its major drivers and restraints at present. Regulatory concerns are also addressed in the report, which talks about the various regulatory criteria that products in the laxatives market need to match in order to be commercialized. The leading players in the global laxatives market are also assessed in the report with the aim of providing readers with a comprehensive overview of the market’s competitive landscape.

 

Laxatives are substances taken to bring about defecation in cases of bloating or constipation. These substances act on the muscles in the intestines to bring about stronger contractions, which allow for smoother movement of the feces through the guts. Laxatives also work on the principle of enhancing the movement of water towards the large intestine, which is a key factor enabling smooth bowel movements. The growing prevalence of constipation in the urban populace, which has easy access to over the counter medication, is likely to be a major driver for the global laxatives market over the forecast period. Other factors such as the growing prevalence of a sedentary lifestyle and obesity are also likely to play a key role in the growth of the laxatives market over the forecast period.

 

On the other hand, the risk of overuse and abuse of laxatives is the primary threat acting against the global laxatives market. Laxative overuse can, paradoxically, result in constipation, as the body’s muscles stop reacting to the constant stimulation provided by the laxatives. The product landscape of the laxatives market is also littered with a number of products that make unverifiable claims, leading to further customer dissatisfaction and health risks. This is likely to be a key restraint against the global laxatives market over the forecast period.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2772

 

Laxatives Market Competitive Analysis:

Leading players in the global laxatives market include Takeda Pharmaceutical Company, Abbott Laboratories, GlaxoSmithKline, Bayer AG, Boehringer Ingelheim GmbH, and AstraZeneca plc. Leading players in the global laxatives market are likely to focus on product development in the coming years, as the need to develop risk-free, safe laxative formulations that still offer high efficacy has come to the fore in the laxatives market.

 

Laxatives Market Segmentation:

The global laxatives market is segmented on the basis of mechanism of action, type, route of administration, and region.

By mechanism of action, the global laxatives market is segmented into bulk forming, emollient, stimulant, osmotic, and others. Bulk forming laxatives hold the dominant share in the global laxatives market, accounting for close to 30% of the global market in 2016. Emollients account for around 25% of the market.

By type, the global laxatives market is segmented into organic and synthetic.

By route of administration, the global laxatives market is segmented into oral and rectal.

 

Laxatives Market Regional Analysis:

North America is the largest regional market for laxatives, followed by Europe. Asia Pacific is expected to exhibit the highest growth in the global laxatives market over the forecast period.

 

The high consumption of junk food, growing prevalence of obesity, and increasingly sedentary lifestyles in North America have been instrumental to the region emerging as the largest market for laxatives. North American consumers are highly aware about laxatives and regularly consume them to get rid of bloating. The growing consumer awareness about laxatives is likely to be a major driver for the laxatives market in North America over the forecast period. The growing presence of leading players in the region is also likely to drive the stature of the laxatives market in North America over the forecast period.

 

The Asia Pacific market for laxatives is mainly driven by the growing pharmaceutical industry and the growing adoption of sedentary lifestyles, especially in urban regions, which is a major factor in causing constipation.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/laxatives-market-2772

Source: http://www.marketresearchfuture.com/reports/laxatives-market-2772

Rapid Sterility Testing Market 2019 Overview, Segmentation, Application, Technology, Industry Challenges, Trends And Forecast To 2023

Rapid Sterility Testing Market Overview:

Global rapid sterility testing market, as opined by Market Research Future (MRFR) in their recently published report, is expected to leap from its market valuation of USD 158 million in 2017 with a CAGR of 13.4% during the forecast period (2018-2023). Rapid sterility testing is known for its prolific ability of microbial contamination detection from a biologic sample. The testing has widespread use in sectors such as pharmaceutical, biotechnology, and medical devices. In quality control of devices, it is used to test for sensitivity and maintain specificity.

 

The global market is benefiting much from the advanced technological usage of sterility testing such as ATP bioluminescence, colorimetric growth detection, and autofluorescence detection. The rising investment in the research and development of the healthcare sector, along with demands for cutting-edge products from the pharmaceutical sectors are expected to provide substantial thrust to the market. The inclusion of rapid sterility testing helps in fast launching of products and reduce errors in due processes. It is also witnessing several strategic stances being taken by market titans to ease the way towards progress.

 

On the flip side, the rapid sterility testing market could get hindered by the high product cost and availability of alternative methods can hold back the market growth.

 

Avail Free Sample Copy

at https://www.marketresearchfuture.com/sample_request/6621

 

Rapid Sterility Testing Market Segmental Analysis:

MRFR in their report on the global rapid sterility testing market segmented it by product, technology, and application. This segmentation reveals both volume-wise and value-wise growth possibility for a comprehensive understanding of the entire market.

 

Based on the product, the rapid sterility testing market can be segmented into kits & reagents, instruments, and services. The biological kits & reagents segment has the maximum market share as of 2017 due to its substantial use in research and laboratories.

 

Based on technology, the rapid sterility testing market comprises membrane filtration, ATP bioluminescence, and other technologies. The ATP bioluminescence segment is helming the overall segment and is gaining significant momentum to profit more during the review period.

 

Based on the application, the rapid sterility testing market includes pharmaceutical & biological manufacturing, medical device manufacturing, and other end-users. The medical device manufacturing segment is gaining substantial fortune due to the rising demand from the healthcare sector.

 

Rapid Sterility Testing Market Regional Analysis:

MRFR’s region-specific analysis of the global rapid sterility testing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). The aim is to identify growth pockets to understand regional growth better.

 

The Americas is expected to dominate the rapid sterility testing market. The credit goes to a superior infrastructure that encompasses a robust healthcare infrastructure and strong research and development sector owing to high expenditure capability. Additionally, both pharmaceutical and medical device industry are providing much-needed thrust.

 

Europe is ranked second, and its features are quite similar to that of the Americas owing to which the regional market is witnessing growth. The APAC market is witnessing rapid growth as several countries such as China, Japan, Republic of Korea, India, Australia have developed a substantially strong healthcare sector. Its growth could surpass others during the forecast period. However, the MEA market is showing some moderate growth owing to its poor infrastructure in healthcare and research & development.

 

Rapid Sterility Testing Market Competitive Landscape:

Influential companies, as recorded in the MRFR report, to boost the global rapid sterility testing market are Gibraltar Laboratories (US), Charles River Laboratories, Inc. (US), Merck KGaA (Germany), bioMérieux (France), Rapid Micro Biosystems, Inc. (US), Becton, Dickinson, and Company (US), Eurofins Scientific (Luxembourg), Sartorius AG (Germany), FOCUS Laboratories (US), and Thermo Fisher Scientific (US). Strategic decisions and implementations are at the core of the holistic growth of both the company and the market.

 

In September 2018, The US Pharmacopeial Convention (USP) decided to launch a new chapter for rapid sterility testing of short-life products. In doing so, it will follow recommendations made by a panel of experts and stakeholders. 

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/rapid-sterility-testing-market-6621

Vanishing Bone Disease Market Analysis 2019-2023: Key Findings, Regional Analysis, Key Players Profiles

Global Vanishing Bone Disease Market Research Report: Diagnosis (X-Rays, CT Scans, MRIs, Ultrasound, Nuclear Medicine, Others), Treatment (Medicine Therapy, Radiation Therapy), End-User (Hospitals, Diagnostic Centers, Others) – Global Forecast Till 2023

 

Vanishing Bone Disease Market – Overview

Improved research in the medical sector is expected to motivate the growth of the vanishing bone disease market. Reports that evaluate the medical device industry has been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The market is prepared to register a CAGR of 6.1 % approximately in the forecast period.

The market for vanishing bone disease has gained traction in recent times as the occurrence rate of the disease has improved significantly. Significant developments achieved in the therapeutic intervention are expected to create better scope for growth of the vanishing bone disease market in the coming period.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6147

 

Segmental Analysis

The segmentation of the vanishing bone disease market is carried out on the basis of the treatment, diagnosis, region, and end-user. Based on the diagnosis, the vanishing bone disease market is segmented into CT scans, X-rays, MRIs, nuclear medicine, ultrasound, and others. Based on the treatment, the vanishing bone disease market is segmented into radiation therapy and medical therapy. The medicine therapy segment is additionally segmented into vitamin D, bisphosphonates, interferon, a-2b interferon, bleomycin, calcium, androgen, adrenal extracts, and others. The radiation therapy segment is further segmented into thoracic duct ligation, pleurectomy, chest drainage, pleurodesis, and others. By end-users, the vanishing bone disease market is segmented into diagnostic centers, hospitals & clinics, ambulatory surgical centers, and others. On the basis of Geography, the vanishing bone disease market has been segmented into Europe, Asia Pacific, America, and the Middle East and Africa.

 

Vanishing Bone Disease Market Regional Analysis   

The regional examination of the vanishing bone disease market comprises of regions such as Europe, the Americas, Asia Pacific, the Middle East & Africa. The North American region controls the vanishing bone market owing to the current well-established healthcare system and the growing incidences of rare diseases. The European region holds the next biggest market share in the vanishing bone disease market. It is predicted that the government backing for research & development spending and growing incidences of rare diseases is expected to push the European region’s vanishing bone disease market. The Asia Pacific regional market in the vanishing bone disease market is motivated by countries like the Republic of Korea, China, Japan, India, Australia, and Rest of Asia Pacific. The increasing healthcare spending motivates the market development in this region, growing occurrences of atypical diseases, rising bone disorders, and technological progress in the interventional radiology segment. The Middle Eastern and African region holds the lowest portion of the vanishing bone disease market owing to deficiency of awareness of rare diseases, the low-frequency rate of the disease and deprived medical facilities, particularly in the African region.

 

Vanishing Bone Disease Market Competitive Analysis

The surge in e-commerce activities is expected to motivate the market in the upcoming years. The fiscal policies that are in effect in the market are expected to lead to a robust pace of development. The level of competitiveness of the environment in the market is expected to be reasonable as there is ample scope for progress. The market is anticipated to display positive signs for market growth in the approaching period. The demographic changes are expected to show a positive effect on the progress of the market. The leverage created by the companies by deploying marketing strategies and activities is further enhancing the expansion of the market. The enhancement of production facilities is expected to motivate the market’s progress. The trade liberalization in the market and technological developments are expected to encourage the development of the market in the approaching years.

 

R. Bard Inc., Medtronic plc., Vygon S.A., Sanofi-Aventis, Cook Medical, Smiths Medical, Teleflex Incorporated, ATMOS MedizinTechnik GmbH & Co. KG, Varian Medical Systems, Inc., Merck & Co., Elekta AB, F. Hoffmann-La Roche AG, and Novartis International AG are some of the outstanding competitors in this market.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/vanishing-bone-disease-market-6147

Source: http://www.marketresearchfuture.com/reports/vanishing-bone-disease-market-6147

Spina Bifida Market Analysis, Growth Prospects, Application, Solutions, Developments Status, Technology, Segmentation, Trends, Business Opportunities 2019-2023

Spina Bifida Market Overview

Spina bifida is a birth defect when there is improper formation of the spine and spinal cord resulting in symptoms, such as weakness of the lower limbs, urinary and bowel incontinence, poor skin sensation, swelling at the site of spine, build-up of cerebrospinal fluid and others.

 

Global Spina Bifida Market size is expected to surge owing to growing awareness, healthcare expenditure, and the growing success rate of medical intervention. Spina Bifida perceives a massive demand owing to growing number and reach of hospitals and healthcare infrastructure.

 

As Market Research Future (MRFR) opines, the global Spina Bifida market is expected to register a CAGR of over 8.0% over the assessment period (2016-2027). Growing demand for treatment and the emergence of compulsory screening is a key driving force behind the substantial market demand. Spina Bifida affects about 15% of people in the world and has an average rate of 0.4 to 1.2 per 1000 births, which drives a consistent demand for treatment.

 

The development of advanced shunts is driving a large market. The development of open fetal surgery and fetoscopy may usher a disruptive trend in the market. Additional factors fostering the market demand include the compulsory screening of infants under state laws such as that mandated by California the development of accurate tests such as alpha-fetoprotein test.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5643

 

Global Spina Bifida Market – Segments

The report has four dynamics to widen the scope of understanding,

By TypeOcculta, Closed Neural Tube Defects, Meningocele, And Myelomeningocele, among others.

By DiagnosisBlood Tests (Maternal Serum Alpha-Fetoprotein (MSAFP) Test, Test to Confirm High AFP levels, and Other Blood Tests), Ultrasound, Amniocentesis, among others.

By TreatmentMedical Procedure (Urinary Catheterization, Urinary Diversion, and Enema), Surgery (Spine Surgery, Fetal Endoscopic Surgery, Spinal Fusion, Suprapubic Cystostomy, and Caesarean Section), Oral Medications (Antibiotics, Others), among others.

By End-useHospitals, Clinics, Diagnostic Centres, Drug Stores, Pharmacies among others.

By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.

 

Global Spina Bifida Market – Regional Analysis

The Americas dominate the spina bifida market owing to drivers, such as compulsory screening, rising occurrence of spina bifida in the region, and technological advancements, especially in stents. According to the Centres for Disease Control and Prevention (CDC), almost 1,500 babies suffer from spina bifida per year in the U.S.

Europe accounts for the second-largest spina bifida market which is expected to grow owing to factors such as positive amendments in the reimbursement policies.

 

Asia Pacific is expected to drive the fastest growth owing to a large patient pool and expansion of healthcare. Growing healthcare expenditure and developing economy is providing an impetus to the Asia Pacific market.

 

The Middle East & Africa currently accounts for the lowest share of the global Spina Bifida market owing to factors, such as weak economic development, lack of medical facilities and low income. However, the Gulf states of Saudi Arabia and UAE are expected to drive a large market growth owing to high public healthcare expenditure.

 

Global Spina Bifida Market – Competitive Landscape

The Spina Bifida market appears represents a bimodal curve. The stent market and the number of surgeries is growing owing to the expansion of healthcare. However, the diagnostic market is suffering from influx of a large number of companies. The falling pricing margin on diagnostic kits is a cause of concern. The emergence of China as a low-cost producer of medical devices is shifting the market dynamics.

Manufacturers are developing and using a variety of distributions chains to corner larger market share. Close association with retailers to increase sales and exposure to customers is also being used as a demand enhancing strategy. Outsourcing manufacturing to a low-cost offshore location such as China is also being followed.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/spina-bifida-market-5643

 

Major Players:

Players leading the global Spina Bifida market include Boston Scientific, C.B. Fleet, C.R. Bard, Inc., B. Braun Melsungen AG, ConvaTec Group plc, Hollister Incorporated, Cook Medical, Covidien Private Ltd., Ethicon, Wellspect Healthcare, Fujifilm, KARL STORZ, Pacific Hospital Supply Co., Ltd., Medline Industries, Coloplast A/S, Medtronic plc, Olympus, Smith & Nephew, Dynarex Corporation, Stryker, Teleflex Incorporation, among others.

 

Industry/ Innovation/ Related News:

June 19, 2019 ---- Cleveland Clinic performed the first in-utero fetal surgery to treat a spina bifida congenital disability on a 23-week-old fetus. The surgery was carried out by Dr. Darrell Cass, and his team. The development is significant as it opens up new vistas for the global Spina Bifida market. The development of in-utero fetal surgery is expected to open a nascent but growing market for advanced medical devices. The surgery achieved all measures of quality for fetal repairs such as normal brain structure restoration and birth gestational age.

 

Source: http://www.marketresearchfuture.com/reports/spina-bifida-market-5643

Blood Flow Measurement Devices Market Analysis 2019-2023: Key Findings, Regional Analysis, Key Players Profiles And Future Prospects

Blood Flow Measurement Devices Market Overview

Market Research Future has predicted that the global blood flow measurement devices market will attain a CAGR of 8.8% over the forecast period, 2017-2023.

The global market for blood flow measurement devices market is mainly related to the high prevalence of the cardiovascular disease, high rate of obesity, and the growing need for minimally invasive procedures. In addition, factors such as increased approvals for blood flow measurement equipment, government initiatives and support, increased demand for advanced treatments, research and increased clinical trials for blood flow measurement equipment and increasing players that are offering newer products will probably stimulate the market.

 

Segmentation

Application, product, and end-user are major factors based on which the global blood flow measurement devices market is segmented

Based on the product, the global market is bifurcated into laser doppler blood flow meters, ultrasound, and blood flow meters. The ultrasound subsegment is further classified into digital doppler, multi-range doppler technology, ultrasound doppler, and bilateral doppler, and transit-time flow meters

Further, based on application, the global market is divided into cardiovascular diseases, gastroenterology, diabetes, CABG, tumor monitoring, and microvascular surgery.

The end-user segment is differentiated into ambulatory surgical centers, hospitals and clinics, and specialty centers.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5930

 

Regional Insights

The blood flow measurement devices market in North America is budding at a great pace. The growing number of obese people and the increasing prevalence of cardiovascular disease rates are expected to increase the growth of the blood flow measurement devices market. In addition, a growing need for minimally invasive procedures, higher healthcare costs, increasing registrations of blood flow monitors, and demand for advanced treatments and products is expected to propel the growth of the global market. High tech technology, as well as increasing government support, are likely to stimulate demand for blood flow measurement devices in North America.

 

Europe follows North America and has a large share of the blood flow measurement devices market. The European market is expected to grow over the forecast period due to the availability of newer and more advanced processing facilities, increased health-based spending, and the growing need for better health infrastructure.

 

The Asia Pacific region is expected to become the fastest-growing market. The increasing prevalence of chronic diseases is one of the most important factors for market growth. China is witnessing swift growth in the region due to population growth, leading to an increase in the number of patients. Increasing health awareness and the availability of new treatment methods are the driving forces of the market in this region. Rising healthcare spending and rising living standards are spurring the growth of the Asia Pacific blood flow measurement devices market.

 

The Middle East and Africa would show sluggish growth in the market due to some important factors such as limited access, lack of awareness, and availability of treatment facilities.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/blood-flow-measurement-devices-market-5930

 

Blood Flow Measurement Devices Market Major Players

Industrial players are trying their best strategies to sustain in the highly competitive market. These players functioning in the global blood flow measurement devices market include Medistim ASA, Getinge Group, Cook Medical, Inc., Transonic Systems, Deltex Medical Group PLC, Biopac Systems Inc., and Compumedics Limited among others.

Source: http://www.marketresearchfuture.com/reports/blood-flow-measurement-devices-market-5930

Vaccine Adjuvants Market – Size, Trends, Growth, Industry Analysis, Share And Forecast To 2023

Vaccine Adjuvants Market Information: By Type (Pathogen Components, Particulate Adjuvants, others), By Route of Administration (Oral, Intramuscular, Subcutaneous, and Intradermal), and By End Users (Pediatric, Adult) - Global Forecast Till 2023

 

Vaccine Adjuvants Market Overview

Market Research Future has a half cooked research report on the global vaccine adjuvants market.

 

Vaccine adjuvants instruct the immune system further in launching a countermeasure against the infection. These immunological agents modify the effect of other agents by enhancing the vaccine development process, striking a strong and prominant immune response to the administered antigen (Immunology) and a strong protection against infection. Adjuvants have come up as a vital component for most of the clinically used vaccines.

 

Understanding the application of adjuvants is very essential in analyzing the market dynamics. Several developments are taking place in the antigen research (vaccine). These research and development activities have also been helpful in driving the market growth of vaccine adjuvants.

 

Market Research Future (MRFR) in its recently published study report asserts that the global vaccine adjuvants market is expected to perceive exponential gains by 2022. It has been noted that the market growing at a steady pace will post a CAGR of 10.1% during the forecasted period 2017 – 2023. Surpassing its previous growth records in terms of value & volume, the market is expected to gain prominence over the forecasted period. 

 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1098

 

Factors influencing the market growth include the increasing government initiatives, proposals and vaccination drives such as Polio, mechanical advancements, and manufactured immunizations.  Immunization programs that government bodies are focusing upon are also expected to drive the demand for vaccine adjuvants. Increase in zoonotic and infectious diseases, along with the demand for improved vaccination against existing and emerging diseases foster the market growth extensively.

Additionally, the increasing use of synthetic vaccines and recombinant are also expected to drive the global vaccine adjuvants market over the forecast period.

 

On the other hand, factors such as high toxicity adjuvants, side effects, stringent regulatory aspects, cost of developing a new adjuvant, lack of awareness about adjuvants and unmet vaccine requirements for specific diseases, are obstructing the market growth.

 

Next generation adjuvants:  Rapid progress in molecular immunology has advanced vaccine adjuvant discovery efforts, enabling the use of cellular and target-based assays to screen an array of chemical compounds for potential use as immune potentiators. How to deliver these new adjuvant compounds is the challenge, particularly for use in existing vaccines which are commonly used  as adjuvants e.g. Insoluble aluminum salts.

A recently discovered adjuvant active compounds called Small Molecule Immune Potentiators (SMIPs) which enable adsorption of aluminum hydroxide adjuvant via the mechanism of ligand exchange. It is a novel approach and an overview of in-vitro and in-vivo performance of the new generation adjuvants. 

 

Global Vaccine Adjuvants Market – Segmentations

The MRFR analysis segmented into four key dynamics for the convenience of the report and enhanced understanding;

By Types: Pathogen Components, Particulate Adjuvants, others.

By Routes of Administration: Oral, Intramuscular, Subcutaneous, and Intradermal.

By End-Users: Pediatric and Adults

By Regions:  North America, Europe, APAC and Rest-of-the-World.

 

Vaccine Adjuvants Market – Regional Analysis                               
North America dominated the Global Vaccine Adjuvants market with the largest market share, accounting for a fabulous growth records and is expected to grow further by 2023. A proliferated healthcare sector, well-spread awareness towards the benefits of vaccination in preventing the communicable and non-communicable diseases and favorable conditions for research and development are some of the factors substantiating the market growth in region.

 

The European market for vaccine adjuvants is expected to grow at a substantial GAGR during 2017-2023, closely following the North American market. Factors such as the availability of funds for research and development activities, and growing initiatives taken by the government and NGOs for diseases preventive measures are fostering the market growth.

 

Asia Pacific is expected to grow at a considerable CAGR during 2017 – 2023, emerging as one of the most lucrative markets for vaccine adjuvants. Increasing prevalence of communicable diseases in the region is the dominant driving force for the market growth. India and China backed by the improvement in the healthcare domain, and increasing prevalence of diseases are providing impetus to the market growth in the APAC.

The market in the Middle East & Africa region will witness a sluggish growth due to lack of awareness, poor medical facilities, and less emphasis on research and development activities. 

 

Global Vaccine Adjuvants Market – Competitive Analysis

Matured players having a strong foothold in the global and regional market adorn the global Vaccine Adjuvants market as highly competitive and fragmented. The vaccine adjuvants market is no exception when it comes to adopting strategies and trends, to churn the competitive advantage to sustain the market position.

 

They adopt the same prevailing trends such as M&A or strategic collaboration, investments in local manufacturers in developing nations, product developments and manufacturing activities. Also, some pharmaceutical giants have invested heavily in the field of Vaccine Adjuvants, which has interpreted as a capacity expansion plan and intensive R&D with the aim of obtaining vast growth opportunities.

 

Key Players

Vaxine Pty Ltd (Australia), VaxLiant LLC.(US),Aphios Corporation (US), Adjuvatis (France), Viscogel AB (Sweden), Sergeant Adjuvants (US), CureVac AG (Germany), Sigma-Aldrich Co. LLC.(India), Brenntag Biosector (Denmark), SEPPIC (France), CSL Limited (Australia), Agenus, Inc. (US), SPI Pharma, Inc.(US), Novavax, Inc.(US), Avanti Polar Lipids, Inc. (US), Invivogen (US), OZ Biosciences (France), and MPV Technologies (US) are some of the key players profiled in the MRFR Analysis.

 

Get More Information on Vaccine Adjuvants Market Research Report - Global forecast till 2023 @ https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

 

Industry and Related News:

July 11, 2018 – Scientists at Trinity University Dublin, (Ireland) published their new research about the new adjuvant they developed in The Journal of Immunology. The adjuvant can kick-start the immature infant’s immune system and can be helpful while administering vaccines to infants and newborns.

Source: http://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

Brain Monitoring Market 2019 Production Value, Gross Margin Analysis, Development Status, Business Strategy And Industry Segments

Global Brain Monitoring Market Information, by devices (Intracranial pressure monitor, Magneto encephalography (MEG), Electroencephalograph (EEG), Cerebral oximeters, and Transcranial Doppler), by Procedure (invasive and non-invasive), by modality (Portable EEG devices, Fixed EEG devices), by end users (Hospitals, diagnostic center) - Forecast to 2022

 

Brain Monitoring Market Overview:

Brain monitoring is an essential process to study and report the functioning of the brain. With the incorporation of advanced technology in the healthcare sector, various advanced medical devices have been launched to monitor the brain cells effectively. According to the report published by Market Research Future (MRFR), the global brain monitoring market is registered to project expansion at a moderate rate in the next five years.

 

Brain Monitoring Market Drivers and Restraints:

Global increase in incidences of neurological disorders due to changing lifestyle and increasing stress levels have induced a high demand for advanced monitoring systems to accurately diagnose the root cause of disorders, which is projected to be fuelling the growth of the global brain monitoring market. Increase in cases of depression, brain injuries caused in road accidents and other neurological disorders are majorly driving the expansion of the global brain monitoring market.

 

Rapid advancement in technology has resulted in the introduction of highly effective brain monitoring systems and devices, leading to the significant expansion of the global brain monitoring market. However, the lack of awareness regarding the availability of advanced brain monitoring technology and poor primary health care services in the underdeveloped regions are likely to create hindrance in the growth of the global brain monitoring market during the forecast period.

 

Get More Information on Global Brain Monitoring Market Research Report- Forecast To 2022 https://www.marketresearchfuture.com/reports/brain-monitoring-market-2288

 

Brain Monitoring Markett Segmentation:The global brain monitoring market has been segmented on the basis of devices, procedure, mobility and end users. Based on devices, the brain monitoring market has been segmented into intracranial pressure monitor, magneto encephalography (MEG), electroencephalograph (EEG), cerebral oximeters, and transcranial doppler. Based on procedure, the brain monitoring market has been segmented into invasive and non-invasive. Based on modality, the brain monitoring market has been segmented into portable EEG devices and fixed EEG devices. Based on end users, the brain monitoring market has been segmented into hospitals, diagnostic center and others.

 

Regional Analysis:

Geographically, the global brain monitoring market is segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. The brain monitoring market in the North America region is expanding at a significant pace owing to the easy adoption of advanced technology in the well-developed healthcare sector of this region. The Europe region is growing at a noteworthy rate in the global brain monitoring market owing to the increasing healthcare expenditure and rise in incidences of neurological disorders among the population of this region.

 

Brain Monitoring Industry Updates:

In January 2018, Masimo, an American developer of non-invasive patient monitoring technologies, has received FDA approval for home use of Rad-97, its new product that offers non-invasive pulse oximetry and continuous monitoring.

In February 2018, Elekta, a Swedish company that provides radiosurgery, radiation therapy, related equipment and clinical management for treatment of brain disorders and cancer, has received clearance from China Food and Drug Administration (CFDA) for its new product, Leksell Gamma Knife Icon Radiosurgery System.

 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/2288

 

Brain Monitoring Market Key Players:

The prominent players profiled by MRFR in the report on the global brain monitoring market are Philips Healthcare (Netherlands), Medtronic plc (Ireland), Natus Medical Inc. (the U.S.), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), GE Healthcare (the U.K.), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (the U.S.), CAS Medical Systems, Inc. (the U.S.), and Advanced Brain Monitoring (the U.S.).

Source: http://www.marketresearchfuture.com/reports/brain-monitoring-market-2288

Peripheral Artery Disease Market Review, Future Growth, Global Survey, In-Depth Analysis, Share, Key Findings, Company Profiles, Comprehensive Analysis, Historical Analysis,

Global Peripheral Artery Disease Market Research Report: By Disease Type (Organic and Functional), Treatment Type (Medications, Angioplasty, Bypass Grafting, Atherectomy, Thrombolytic Therapy and others), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

 

Peripheral Artery Disease Market Scenario

Following a careful analysis of the global peripheral artery disease market, Market Research Future (MRFR) concludes that it will reach the valuation of USD 3.47 billion by 2023. The market is set to rise from its previous value of USD 2.23 billion in 2016, at a CAGR of 6.5% during the forecast period (2017-2023).

 

Growth Factors and Key Restraints

Rise in Geriatric Population

There has been a dramatic surge in the number of aging people worldwide. As per a WHO report, at least 524 million people were above the age of 65 in the year 2010, and the prediction is that number will be reaching 1.5 billion by 2050. This figure is expected to constitute almost 16% of the total global population. Furthermore, the number of elderly individuals is directly proportional to the number of disorders amongst them, like hypertension and diabetes, increasing the risk for peripheral artery disease. Thus, the expanding geriatric population will leave a positive impact on the growth of the global market in the years to come.

 

Get a FREE Sample Copy of Report with Complete TOC

https://www.marketresearchfuture.com/sample_request/1540

 

Advanced Treatment Options

The peripheral artery disease market size is all set to expand significantly from 2017 to 2023, with a key reason being the increasing advanced treatment options as well as tools like atherectomy devices. These kinds of tools are used for debulking the plaque before using a stent for treatment. Thus, with the surging prevalence of calcified and hard lessions coupled with the upgraded atherectomy procedure, the overall growth of the market is going to be highly promising in the forthcoming years. Apart from this, other latest interventional products like drug eluting stents and drug coated balloon stents will also prove to be instrumental in the lucrative growth of the market during the conjectured time frame.

 

Increase in Research and Development Expenditure

Adding on to the list of growth drivers, one factor that will give a substantial boost to the market growth is the rising research and development expenditure. As per reports by European Federation of Pharmaceutical Industries and Association, in 2016, the R&D expenditure in the Pharmaceutical Industry was estimated at a whopping value of EUR 35000 million. Moreover, as per the Centers for Disease Control and Prevention, in 2015, the per capita national health expenditure was approximately USD 9,990, with the total national health expenditure being USD 3.2 trillion. Also, few reports suggest that out of total national health expenditures in the United States (US), the prescription drugs accounted for 10.1% of the total share.

 

Rising Trends in Peripheral Artery Disease Market

At present, the peripheral artery disease market is governed by numerous players. Also, as a result of the increasing research and development expenditure, a number of existing as well as new marketers are progressively developing advanced drugs that can control this specific condition.

 

For instance, Medtronic is one such company in the peripheral artery disease market, that is one of the largest standalone medical equipment development company in the world. The company boasts of a diverse portfolio of a range of products like NC Sprinter RX/ OTW Noncompliant Balloon Dilatation Catheter, NC Euphora Noncompliant Balloon Dilatation Catheter, Euphora Semicompliant Balloon Dilatation Catheter, among others.

 

Peripheral Artery Disease Market Segmentation

The market for peripheral artery disease is segmented on the basis of devices, drugs and types of diseases.

The global peripheral artery disease market, by the types of devices, is segmented into stents, angioplasty balloon catheters, drug-eluting balloons, atherectomy devices and others. Stents is sub-segmented into balloon-expandable and self-expandable, whereas the atherectomy devices are sub-segmented into rotational, orbital, laser and directional.

The types of drugs used for treating peripheral artery disease include lipid-lowering drugs, blood pressure lowering drug, glucose regulating drug, clot preventing drug and others.

 

The types of diseases mentioned in the report are blood clotting disorders, lymphedema, atherosclerosis and others.

 

Regional Insight

The regional segments in the global peripheral artery disease market are Asia Pacific, Europe, North America, and the Middle East & Africa.

 

With the largest share in the global market, North America seems to be on an upward trajectory due to the increasing number of people suffering from major or minor peripheral diseases. Moreover, the increasing obese and diabetic patients in the region has accelerated the demand for the drugs needed for the treatment of peripheral artery diseases. Other factors working in favor of the regional market include the growing awareness regarding the disease, favorable reimbursement policies, as well as expanding geriatric population.

 

On the other side, the growing population in the Asia Pacific region coupled with the speedy rate of development is luring numerous manufacturers to the region. This will be a key reason for the lucrative growth rate of the regional market in the coming years. Apart from this, Asia Pacific also presents lucrative opportunities to the market, in the form of surging awareness among patients about the latest interventional treatment options.

 

The growth drivers of the peripheral artery disease market in Europe include the improved screening and detection of the disease, the rising geriatric population, and the continuous advancements in technology. Of course, the strikingly improving healthcare infrastructure and the healthcare industry has also been one of the most important factors in the market growth over the years.

 

The Middle East and Africa peripheral artery disease market will also be making somewhat similar strides as other regional markets, backed by the growing interest for minimally invasive strategies, evolving lifestyle, maturing population and the upsurge of peripheral artery diseases. 

 

Peripheral Artery Disease Market Key Vendors

Bayer HealthCare Pharmaceuticals (Germany), TheraVasc Inc. (US), Abbott Laboratories (U.S), AstraZeneca Plc. (UK), Boston Scientific Corporation (U.S), Johnson & Johnson (U.S), Medtronic (Ireland), Betagenon AB (Sweden), nGes MG, Inc. (Japan), Proteon Therapeutics, Inc. (US), Merck & Co., Inc. (US), Angioscore, Inc. (U.S), Symic Bio, Inc. (US), CardioVascular BioTherapeutics, Inc. (US), Bristol-Myers Squibb Company (US), Sanofi S.A. (France), are among some of the top players in the global peripheral artery disease market.

 

Get More Information on Peripheral Artery Disease Market Research Report - Global Forecast till 2025 https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540

 

Industry Developments

February 2019 - Mercy Hospital (US) is all set to offer a supervised exercise therapy program for those afflicted with symptomatic Peripheral Artery Disease (PAD). The 12-week supervised exercise therapy program will involve treadmill walking, along with various other exercise modalities, supervised by exercise physiologists, who will ensure the safety of patients.

Source: http://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540

Urinary Tract Infection (UTI) Market Size, Share, Growth Drivers, Investment Opportunities, Strategic Assessment, Trend Outlook And Key Findings

Urinary Tract Infection (UTI) Market Analysis

Global urinary tract infection market is poised to surpass USD 9.89 billion at a significant 3.6% CAGR over the estimated years (2017-2023). UTI or urinary tract infection is an infection occurring in the upper or lower urinary tract including the urethra and the bladder. UTIs are of two types - urethritis and cystitis. The former is an infection that is takes place in the urethra while the latter is an infection that takes place in the bladder. Getting this infection is easy. Bacteria that lives in the genital, vagina and anal areas can enter the urethra and travel the bladder thereby causing infection. The common symptoms related to UTI include burning and painful sensation while urinating and frequent, strong urge to urinate. The primary causes of urinary tract infection include obesity, diabetes, bowel incontinence, poor personal hygiene, sexual intercourse, enlarged prostate gland and blockage in the urinary tract mainly kidney stone.

 

There are abundant factors that is propelling the growth of the urinary tract infection market. These factors as per the MRFR (Market Research Future) report include increase in hospital-borne infections, rising geriatric population, emergence of drug-resistant bacteria, rising health awareness amid women, increase in diagnosis, prevalence rate of diseases mainly kidney stone and diabetes, increasing incidences of UTI, changing lifestyle pattern, favorable reimbursement policies and higher treatment compliance. On the contrary, increasing market fragmentation, loss of patents, unmet clinical needs, growing drug resistance, lack of awareness amid people, strict government regulations, adverse effects of medications, poor patient compliance and generic erosion are factors that may restrict urinary tract infection market growth.

 

Get a FREE Sample Copy of Report with Complete TOC

https://www.marketresearchfuture.com/sample_request/6138

 

Urinary Tract Infection (UTI) Market Segmentation

MRFR report offers a broad segmental analysis of the urinary tract infection market on the basis of drug class, clinical indications and end users.

Based on drug class, it is segmented into azoles, β-lactam, aminoglycosides, quinolones and others.

Based on clinical indications, the urinary tract infection market is segmented into pyelonephritis, cystitis, urethritis and others.

Based on end users, it is segmented into self-administered, hospitals and others.

 

Regional Analysis

By region, the urinary tract infection market covers growth opportunities and latest trends across North America, Europe, Asia Pacific, and Middle East and Africa. Of these, North America will stay at the forefront in the urinary tract infection market over the estimated years owing to increasing prevalence of diseases especially diabetes, high diagnostic rate and increasing healthcare awareness. US is the key contributor here. The current regulatory shift in the United States including Hospital Readmissions Reduction Program coupled with Affordable Care Act and also Medicare initiatives for penalizing unnecessary patient readmissions is likely to drive the UTI market in the US. The urinary tract infection market in Europe will have the second major share over the estimated years due to increasing research and development and higher hospitalization rate. In the APAC region, the urinary tract infection market is predicted to grow at the fastest pace with India and China being the key contributors. Factors that are resulting in the growth of the market in this region include increased disposable income, growing healthcare infrastructures, gradual use of improved technologies, increasing rate of diagnostics, growing personal care & hygiene and growing awareness. Besides, rising geriatric population is also a factor that is anticipated to increase the demand for UTI therapeutics with the population being at the risk of developing the infection.

 

Get More Information on Urinary Tract Infection (UTI) Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/urinary-tract-infection-market-6138

 

Urinary Tract Infection (UTI) Market Key Players

Leading players profiled in the urinary tract infection market include Johnson & Johnson, Cipla Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Pfizer Inc., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Novartis AG, Bayer AG and others.

 

April 2019- Professor Douglas Kell along with his colleagues have come up with a new technology which can help to identify the most powerful antibiotic for killing organisms in UTI. This new technology will play a pivotal part in fighting anti-microbial resistance. It uses flow cytometry that can detect and count individual bacteria present in the urine sample as well as decide which antibiotic will be the most efficient to kill those bacteria. The patient will then be prescribed with an antibiotic that is the most effective.

Source: http://www.marketresearchfuture.com/reports/urinary-tract-infection-market-6138

Infertility Market 2019: Global Analysis, Business Strategy, Development Status And Trends By Forecast 2023

Global Infertility Market Information; By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, And Other) And Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography And Others)) And General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging, And Others), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment And Others), By Techniques (Assisted Reproductive Technology (Art), Intrauterine Insemination, And Surgery (Laparoscopic Or Hysteroscopic Surgery, Tubal Surgeries And Others) And Others) - Forecast To 2023

Infertility Market Analysis

Global Infertility Market is eyeing for a steady growth at a phenomenal 4.6% CAGR over the assessment period (2017-2023).  Infertility is a form of medical condition that is observed both in women and men. Simply put, it is an individual’s inability of reproducing naturally. Some of the common causes of infertility in men include abnormal sperm function or production, genetic problems, diabetes mellitus, DNA damage, issues with delivery of sperm, overexposure to specific environmental factors, damage associated to cancer and more. Here the environmental factors include exposure to pesticides, radiation, alcohol, smoking, taking certain medications and regular exposure to heat. On the other hand, the common causes of infertility in women include ovulation disorders, cervical or uterine abnormalities, fallopian tube blockage or damage, endometriosis, early menopause and pelvic adhesions. The other causes include cancer and its associated treatment and other conditions such as genetic abnormalities, absence of menstruation, ruptured appendicitis, polycystic ovary syndrome, and medical conditions related to delayed puberty. There are a couple of risk factors related to infertility both in women and men. These include age, tobacco use, alcohol use, being overweight, being underweight, exercise issues, increasing age at marriage, sedentary lifestyle, stress, hormonal disorders, anabolic steroid use, abdominal surgery and more.

There are many factors that is driving the growth of the infertility market. Some of these factors as per the Market Research Future (MRFR) report include declining rate of fertility, increasing number of fertility clinics, advancements in technology, increasing grants, funds and public-private investments, lifestyle disorders, increasing awareness about infertility, accessibility of advanced infertility treatment devices and treatment option and advent of various assisted reproductive techniques. On the contrary, factors such as complications and risk related to infertility treatment, soaring procedural cost, unsupportive government regulations, poor efficacy of infertility treatment, social taboos concerning the treatment and side effects of drug therapy is likely to act as major barriers in the infertility market growth.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6145

Infertility Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the infertility market on the basis of sex, diagnosis, drugs and techniques.

Based on sex, it is segmented into females and males. Of these, females will have the largest share in the infertility market over the assessment period owing to accessibility of a wide variety of treatment processes and decrease in female fertility.

Based on diagnosis, the infertility market is segmented into men diagnostic tests (testicular biopsy, genetic testing, semen analysis and others), women diagnostic tests (hysterosalpingography, ovulation testing, laparoscopy, hysteroscopy and others) and general diagnostic tests (imaging, microscopic analysis, hormone testing, genetic testing and others).

Based on drugs, it is segmented into hormone treatment, serophene, letrozole, clomiphene citrate and others.

Based on techniques, the infertility market is segmented into surgery, intrauterine insemination and assisted reproductive technology (ART). Surgery is further segmented into tubal surgeries, hysteroscopic or laparoscopic surgery and others. Of these, assisted reproductive technology (ART) will lead the market owing to advancements in technology and lifestyle disorders.

Infertility Market Regional Analysis

Based on region, the infertility market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will dominate the market with the US being the largest contributor in this region owing to favorable reimbursement scenario, high income and rising pool of awareness. The infertility market in Europe will have the second largest share and the major contributors in this region include the UK, France and Germany. The key factor that is droving the growth of the market in this region is the technological advancements being made in the infertility treatment. The infertility market in the APAC region will be the fastest growing, dominated by India and China. The factors that are driving the growth of the market here include highest male infertility rate in South Asia and large population having unmet needs.

Infertility Market Key Players

Key players profiled in the infertility market include EMD Serono, Inc., Bayer Healthcare, Aetna Inc., Androvia LifeSciences, Zydus Cadila Healthcare Ltd, Andrology Solutions, SCSA Diagnostics, Inc., Halotech DNA and others.

Feb 2019- Scientists have discovered a novel robotic sensor technology which can be utilized for measuring hormones that affect sexual development, menstruation and fertility cheaply and quickly than the current techniques. This technology uses a RAPTER device that will provide clinicians with a more accurate and faster hormone pulsatility diagnosis which affects the reproductive health and result in more targeted and better treatments in case of women.

Get More Information on Infertility Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/infertility-market-6145

Source: http://www.marketresearchfuture.com/reports/infertility-market-6145

Catheter Stabilization Device Market Size, Share, Growth Drivers, Investment Opportunities, Strategic Assessment, Trend Outlook And Key Findings

Global Catheter Stabilization Device Market research report, by Product type (arterial securement devices, chest drainage tube securement devices), Applications (cardiovascular procedures, radiology, respiratory procedures) – Forecast till 2023

 

Market Research Future (MRFR) latest study finds that the global catheter stabilization device market size is set to surge at 7.1% CAGR from 2018 to 2023. Catheter stabilization devices are standard class for suture-free stabilization of peritoneal lavage and nephrostomy and biliary percutaneous drainage catheters.

 

These devices play an important during procedures that involve the use of catheters.  Cardiac, neurology, urological are among the major areas where catheter stabilization finds application. The rising incidence of cardiac incidence is one of the major factors driving the market growth. In 2015, cardiovascular diseases accounted for more than 17 Mn deaths. Of these, over 6 Mn deaths were due to stroke and more than 7 Mn were due to coronary heart diseases. The data released by the American Heart Association cardiovascular diseases accounted for nearly 801,000 deaths in 2017. The healthcare cost of cardiovascular treatment is anticipated to reach USD 1044 Bn by the year 2020. 

 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6944

 

Segmental Overview

MRFR’s study includes a detailed segmental analysis of the global catheter stabilization device market based on application, product type, end user and region.

By application, the market has been segmented into respiratory procedures, general surgery, radiology, cardiovascular procedures, urological procedures, gastric and oropharyngeal procedures and others. By product type, the market has been segmented into arterial securement devices, central venous catheter securement devices, peripheral securement devices, chest drainage tube securement devices, abdominal drainage tubes securement devices, epidural securement devices. The central venous catheter securement devices segment covers jugular securement devices, PICC securement devices, midlines securement devices, portal securement devices, subclavian securement devices and femoral securement devices. The peripheral securement devices segment covers nasogastric tubes securement devices, continuous nerve block catheter securement devices, chest drainage tube securement devices, foley catheter securement devices, endotracheal tube securement devices, ventriculoperitoneal securement devices. Abdominal drainage tube securement devices segment covers umbilical catheter securement devices, jejunal catheter securement devices and percutaneous endoscopic gastrostomy securement devices. By end users, the market has been segmented into diagnostic centers, home healthcare providers and hospitals & clinics.   

 

Global Catheter stabilization device market: Regional Segmentation

On the basis of region, the market has been segmented into Asia Pacific, Europe, Americas and the Middles East & Africa (MEA). The market catheter stabilization device market in Americas is expected to remain highly attractive during the forecast period. Presence of advanced healthcare infrastructure and faster adoption of innovative healthcare technologies are some of factors supporting the market growth in Americas, especially North America.

 

In terms of revenue, Europe holds the second spot. Increased prevalence of chronic diseases and cardiovascular disorders in the region is driving the demand for catheter-based procedures. Moreover, high healthcare expenditure and presence of public healthcare policies continues to favour the market in Europe.

 

Asia Pacific is also viewed as a crucial market for catheter stabilization. In fact, the APAC catheter stabilization device market is projected to witness a relatively faster growth during the forecast period. Growing need for effective diagnostic services and increased focus of improving healthcare infrastructure and an ever-growing patient pools are factors that make APAC a market with significant potentials. 

 

Competitive Analysis

Some of top-notch companies operating in the global catheter stabilization device market include B. Braun Melsungen Ag, C. R. Bard, Inc. Convatec, Inc., Medtronic PLC, M.C. Johnson Company, Inc., 3M Company, TIDI Products, LLC., Baxter International, Inc., Merit Medical Systems, Inc., Centurion Medical Products, and Smiths Group PLC. 

 

Get More Information on Catheter Stabilization Device Market Research Report – Global Forecast till 2023 https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

 

Industry News

  • American healthcare technology company Abbott Laboratories has reportedly received the green signal from FDA for its novel sensor enabled TactiCath Contract Force Ablation Catheter. The catheter has been there in the Europe market for couple of years now. 
  • Penumbra, a healthcare company that develops suction-based stroke clot removal devices has recently introduce two new devices; Penumbra JET 7 and Penumbra JET D Reperfusion Catheters.

 

Source: http://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

Arrhythmia Monitoring Devices Market 2019: Global Analysis, Business Strategy, Development Status, Emerging Technologies, Future Plans And Trends By Forecast 2024

Arrhythmia Monitoring Devices Market Report Information by Device Type (Resting ECG, Event Monitor, Holter Monitor, Others), by Application (Tachycardia, Bradycardia, Others), By End User (Hospitals and Clinics, Others) and Region­­ - Global Forecast till 2024

 

Global arrhythmia monitoring devices market is expected to grow at a strong 7% CAGR over the forecast period from 2018 to 2023, according to a new research report from Market Research Future (MRFR). The global arrhythmia monitoring devices market is mainly driven by the growing prevalence of arrhythmia and rising technological advancement in monitoring devices. The rising healthcare expenditure in emerging regions as well as developed economies is also likely to remain a major factor in the global arrhythmia monitoring devices market’s progress over the forecast period.

 

Arrhythmia monitoring devices are used to monitor the heartbeat of patients with arrhythmias, i.e. fluctuations in the normal rate and pattern of the heartbeat. The heart beating too slowly, too fast, or irregularly can be a sign of deeper, more serious cardiovascular problems. Thus, arrhythmia monitoring devices play an important role in diagnosing cardiovascular conditions and checking their progress. Arrhythmia monitoring devices are useful in not only tracking the heartbeat of a patient over a long period of time, but also in alerting medical authorities in cases of emergency, as rapid changes in the heartbeat patterns can only indicate heart problems. Thus, their use has become widely prevalent in medical establishments all over the world, leading to progress of the global arrhythmia monitoring devices market.

 

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6714

 

The increasing technological advancement in arrhythmia monitoring devices is likely to be a key driver for the market and a key point of contention in terms of the competition in the market. Coming up with more efficient arrhythmia monitoring devices is likely to be rewarded by success and is thus likely to be a key agenda for major players in the global arrhythmia monitoring devices market. The increasing healthcare expenditure around the world is also likely to be a major driver for the global arrhythmia monitoring devices market, as the number of monitoring devices sold in government hospitals in emerging countries is increasing rapidly. The increasing investment in private hospitals in emerging countries is thus also likely to be a major factor for the global arrhythmia monitoring devices market over the forecast period.

 

Segmentation:

The global arrhythmia monitoring devices market has been segmented based on device type, service providers, application, end use, and region.

On the basis of devices, the arrhythmia monitoring devices market has been classified into implantable cardiac monitors, mobile cardiac telemetry devices, resting ECG devices, ECG stress test devices, Holter monitors, and others.

On the basis of service providers, the market is segmented into mobile cardiac telemetry monitoring service providers, independent diagnostic testing facilities/clinics, others.

On the basis of application, the market has been classified as bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, conduction disorders, and others.

On the basis of end use, the arrhythmia monitoring devices market has been segmented into hospitals & clinics, ambulatory surgery centers, diagnostic centers, home care settings, long term care centers, emergency medical services.

 

Regional Analysis:

The global arrhythmia monitoring devices market is likely to be dominated by North America over the forecast period. Widespread availability of technologically advanced arrhythmia monitoring devices in North America, led by the U.S. and Canada, is the major driver for the regional segment. The growing prevalence of cardiac arrhythmias in the U.S., due to lifestyle factors such as sedentary lifestyle and excessive smoking, is likely to be a major driver for the arrhythmia monitoring devices market in the region over the forecast period.

 

Europe also holds a major share in the global arrhythmia monitoring devices market and is likely to remain a leading contributor due to the growing prevalence of arrhythmia in the region. According to the European Heart Network, close to 4 million deaths occur in Europe every year due to cardiovascular diseases.

 

Competitive Analysis:

Leading players in the global arrhythmia monitoring devices market include Cardiac Science Corporation, Koninklijke Philips, Welch Allyn, Nihon Kohden Corporation, BioTelemetry Inc., Biotronik, Abbott, Aurora Resurgence, Medi-Lynx Cardiac Monitoring, Preventice Solutions Inc., iRhythm Technologies Inc., Applied Cardiac Systems, Medtronic, AliveCor Inc., Fukuda Denshi, Spacelabs Healthcare, GE Healthcare, and NUUBO Smart Solutions Technologies.

 

Get More Information on Arrhythmia Monitoring Devices Market Research Report - Global Forecast till 2024 @ https://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-6714

 

Industry Updates:

In February 2019, CardioComm received FDA clearance for a new ECG device named HeartCheck CardiBeat.

Source: http://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-6714